Related Experiment Videos
"Markers" for the MacAndrew and the Cavior heroin addiction MMPI scales
Journal of Studies on Alcohol
|May 1, 1983
Abstract:
The MacAndrew and Cavior scales were not shown to measure "a general addictive propensity."
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The MMPI and the post-traumatic stress syndrome in Vietnam era veterans.
Journal of clinical psychology·1985
Renal patients and their MMPI profiles.
The Journal of psychology·1979
MacAndrew MMPI alcoholism scale: alcoholism and drug addictiveness.
The Journal of psychology·1977
One small step for manuals: Computer-assisted training in twelve-step facilitation.
Journal of studies on alcohol·2006
The impact of alcohol taxation on liver cirrhosis mortality.
Journal of studies on alcohol·2006
Activating action tendencies: The influence of action priming on alcohol consumption among male hazardous drinkers.
Journal of studies on alcohol·2006
A multidimensional developmental model of alcohol use during emerging adulthood.
Journal of studies on alcohol·2006
Spring break trips as a risk factor for heavy alcohol use among first-year college students.
Journal of studies on alcohol·2006
Alcohol, illegal drugs, violent crime, and traffic-related and other unintended injuries in U.S. local and national news.
Journal of studies on alcohol·2006
Mirogabalin, C12H19NO2, and mirogabalin besylate, C12H20NO2+·C6H5O3S.
Acta crystallographica. Section C, Structural chemistry·2026
What is in the bottle? An analysis of the ingredients in menopause supplements.
Climacteric : the journal of the International Menopause Society·2026
Non-Prescribed Gabapentinoid Use: Demographic and Behavioural Risk Profiles in a Large International Sample.
Drug and alcohol review·2026
Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats.
Journal of controlled release : official journal of the Controlled Release Society·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026